Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TYMP encodes an angiogenic factor which promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. Additionally we are shipping Thymidine Phosphorylase Proteins (47) and Thymidine Phosphorylase Kits (25) and many more products for this protein.
Showing 10 out of 121 products:
Human Monoclonal Thymidine Phosphorylase Primary Antibody for IHC (p), WB - ABIN114827
Fox, Westwood, Moghaddam, Comley, Turley, Whitehouse, Bicknell, Gatter, Harris: The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. in British journal of cancer 1996
Show all 4 references for ABIN114827
Human Polyclonal Thymidine Phosphorylase Primary Antibody for EIA, IHC (p) - ABIN359550
Jinfeng, Kimura, Sakurai, Moriya, Mizutani, Hirai: Prognostic role of angiogenesis and its correlations with thymidine phosphorylase and p53 expression in ductal adenocarcinoma of the pancreas. in Hepato-gastroenterology 2007
Show all 2 references for ABIN359550
Human Monoclonal Thymidine Phosphorylase Primary Antibody for ICC, IF - ABIN251182
Nie, Bhat, Al-Saleem, Vonderheid, Hou: Expression of thymidine phosphorylase in lymph nodes involved with mycosis fungoides and sézary syndrome. in Advances in hematology 2011
Human Polyclonal Thymidine Phosphorylase Primary Antibody for IHC (p), WB - ABIN391460
Stenman, Sahlin, Dumanski, Hagiwara, Ishikawa, Miyazono, Collins, Heldin: Regional localization of the human platelet-derived endothelial cell growth factor (ECGF1) gene to chromosome 22q13. in Cytogenetics and cell genetics 1992
S1PR1 (show S1PR1 Antibodies) inhibits the apoptosis of human myeloid leukemia (show BCL11A Antibodies) cells and promotes their proliferation.
These results suggest that S1P (show MBTPS1 Antibodies) signaling plays a role in cell proliferation and drug resistance in multiple myeloma, and targeting this pathway will provide a new therapeutic direction for multiple myelomamanagement.
Increases in gene expression levels of TYMP, DPYD (show DPYD Antibodies), and HIF1A (show HIF1A Antibodies) in tumor tissues at 7 days after the start of CRT (show SLC6A8 Antibodies) may be useful for predicting the efficacy of CRT (show SLC6A8 Antibodies) including S-1 or UFT
the highest expression of GGH (show GGH Antibodies) and EGFR (show EGFR Antibodies) was noted in the left-sided colon; the highest expression of DHFR (show DHFR Antibodies), FPGS (show FPGS Antibodies), TOP1 (show TOP1 Antibodies) and ERCC1 (show ERCC1 Antibodies) was noted in the rectosigmoid, whereas TYMP expression was approximately equivalent in the right-sided colon and rectum
High VEGF (show VEGFA Antibodies) expression was subsequently correlated with a short overall survival rate for patients exhibiting lymph node metastasis (P=0.0128); however, there was no significant difference in overall survival rate regarding the expression levels of TP and CD34 (show CD34 Antibodies)
Pretreatment expression of thymidine phosphorylase/HIF-1alpha (show HIF1A Antibodies) were found to predict pathologic response and outcomes in clinical stage II/III rectal cancer receiving neoadjuvant chemoradiotherapy.
Sphingosine 1-phosphate-induced IL-8 (show IL8 Antibodies) gene expression is mainly regulated via S1PR(1 (show S1PR1 Antibodies)), and its secretion is regulated through S1PR(2 (show S1PR2 Antibodies)) receptor subtype.
multiple lines of evidence demonstrate that S1PR1 (show S1PR1 Antibodies) signaling sets the sensitivity of pDC (show PNKD Antibodies) amplification of IFN responses, thereby blunting pathogenic immune responses
The results indicate that sphingosine 1-phosphate is involved in the migration of precursor T-cell lymphoblastic leukemia-lymphoma blasts in vitro, which is dependent on S1P1 (show S1PR1 Antibodies) expression.
Overexpression of miR148a or inhibition of S1PR1 (show S1PR1 Antibodies) suppressed SKOV3 cell migration and invasion, while restoration of S1PR1 (show S1PR1 Antibodies) expression reversed the suppressive effect of miR148a upregulation on SKOV3 cell migration and invasion.
data identify TYMP as an astrocyte-derived permeability factor, and suggest TYMP and VEGFA (show VEGFA Antibodies) together promote blood-brain barrier breakdown.
TYMP participates in multiple platelet signaling pathways and regulates platelet activation and thrombosis. Targeting TYMP might be a novel antiplatelet and antithrombosis therapy.
Thymidine phosphorylase and UPP1 (show UPP1 Antibodies) double knockout mice showed increased thymidine and deoxyuridine in tissues and developed encephalopathy.
This gene encodes an angiogenic factor which promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. It has a highly restricted target cell specificity acting only on endothelial cells. Mutations in this gene have been associated with mitochondrial neurogastrointestinal encephalomyopathy. Multiple alternatively spliced transcript variants have been identified.
, Thymidine phosphorylase
, S1P receptor 1
, S1P receptor Edg-1
, endothelial differentiation G-protein coupled receptor 1
, endothelial differentiation, sphingolipid G-protein-coupled receptor, 1
, sphingosine 1-phosphate receptor 1
, sphingosine 1-phosphate receptor EDG1
, sphingosine 1-phosphate receptor Edg-1
, endothelial cell growth factor 1 (platelet-derived)
, platelet derived growth factor, endothelial cell